naa a22 4500 510741436 CHVBK 20180411083029.0 cr unu---uuuuu 180411e20130601xx s 000 0 eng 10.1007/s11845-012-0854-1 doi (NATIONALLICENCE)springer-10.1007/s11845-012-0854-1 Dual diagnosis of sarcoidosis and lymphoma [Elektronische Daten] [B. Brady, D. Kamel, J. Kiely, B. Hennessy] Background: Sarcoidosis is a multisystem granulomatous disease of unknown origin with pulmonary and extrapulmonary manifestations. Worldwide it is most often diagnosed in the third and fourth decades and most often affects Swedish, Danish and black patients. The association between malignancy and sarcoidosis has not been conclusively proven. Cancer can eventually occur in patients who have an established diagnosis of sarcoidosis for example, in sarcoidosis-lymphoma syndrome. Sarcoidosis can also subsequently develop in an oncology patient. There are multiple obstacles to confirming epidemiologically the linkage between sarcoidosis and malignancy. Histological verification and clinical acumen are needed to avoid misdiagnosis. The 18 fluorodeoxyglucose (18-FDG) PET has failed to provide a non invasive diagnostic method to differentiate neoplasia from benign sarcoid lesions and tissue diagnosis is essential before commencing a new therapeutic intervention in patients with lymphoma. Methods: We report 3 cases of co-diagnosis of sarcoidosis and lymphoma that were seen in an oncology unit in Drogheda, Co. Louth. Results: Our patients varied in the temporal association between the diagnosis of sarcoidosis and lymphoma as well as their demographic characteristics. Conclusion: These cases help to demonstrate the need for careful clinical, histological and radiological assessment. Royal Academy of Medicine in Ireland, 2012 Sarcoidosis nationallicence Lymphoma nationallicence Non-Hodgkin's lymphoma nationallicence Hodgkin's lymphoma nationallicence Brady B. Department of Medical Oncology, Our Lady of Lourdes Hospital, Drogheda, Co. Louth, Ireland aut Kamel D. Department of Medical Oncology, Our Lady of Lourdes Hospital, Drogheda, Co. Louth, Ireland aut Kiely J. Department of Respiratory Medicine, Our Lady of Lourdes Hospital, Drogheda, Co. Louth, Ireland aut Hennessy B. Department of Medical Oncology, Our Lady of Lourdes Hospital, Drogheda, Co. Louth, Ireland aut Irish Journal of Medical Science Springer-Verlag 182/2(2013-06-01), 283-286 0021-1265 182:2<283 2013 182 11845 https://doi.org/10.1007/s11845-012-0854-1 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s11845-012-0854-1 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Brady B. Department of Medical Oncology, Our Lady of Lourdes Hospital, Drogheda, Co. Louth, Ireland aut NATIONALLICENCE 700 1- Kamel D. Department of Medical Oncology, Our Lady of Lourdes Hospital, Drogheda, Co. Louth, Ireland aut NATIONALLICENCE 700 1- Kiely J. Department of Respiratory Medicine, Our Lady of Lourdes Hospital, Drogheda, Co. Louth, Ireland aut NATIONALLICENCE 700 1- Hennessy B. Department of Medical Oncology, Our Lady of Lourdes Hospital, Drogheda, Co. Louth, Ireland aut NATIONALLICENCE 773 0- Irish Journal of Medical Science Springer-Verlag 182/2(2013-06-01), 283-286 0021-1265 182:2<283 2013 182 11845 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer